Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
104.51
-0.36 (-0.34%)
At close: Feb 13, 2026, 4:00 PM EST
106.91
+2.40 (2.30%)
After-hours: Feb 13, 2026, 7:53 PM EST
Celcuity Market Cap
Celcuity has a market cap or net worth of $4.84 billion as of February 13, 2026. Its market cap has increased by 1,036.50% in one year.
Market Cap
4.84B
Enterprise Value
4.70B
1-Year Change
1,036.50%
Ranking
Category
Stock Price
$104.51
Market Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $4.84B, an increase of 3,511.51%. That is a compound annual growth rate of 53.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 4.85B | 5.14% |
| Dec 31, 2025 | 4.62B | 849.61% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
| Sep 20, 2017 | 133.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunovant | 5.33B |
| Structure Therapeutics | 5.19B |
| Protagonist Therapeutics | 5.11B |
| Crinetics Pharmaceuticals | 4.82B |
| Scholar Rock Holding | 4.71B |
| Amicus Therapeutics | 4.50B |
| CRISPR Therapeutics AG | 4.49B |
| Apogee Therapeutics | 4.36B |